Buyers wanting roadmap certainty (ChurnZero more stable), large enterprise (Gainsight deeper), or buyers who prefer founder-led independent vendors (Vitally cleaner story).
Tech-forward mid-market SaaS (50-2,000 employees) that chose Catalyst pre-merger, or new buyers explicitly accepting the merger integration risk for the modern UX advantage.
Why we say this
Editorial pulled these weaknesses from Catalyst’s product card in our Top 10 Customer Health Scoring Software for 2026:
- ! Totango merger 2024 left post-merger product roadmap unclear; existing customers should plan for renewal-cycle uncertainty through 2026
- ! Feature depth still catching up to Gainsight at enterprise tier
- ! Engineering team reorganization affecting feature shipping pace 2024-2025
If Catalyst is wrong for you, consider these instead
Same Customer Health Scoring Software category, different best-fit buyer.
Best for
Enterprise customer success orgs (100+ CSMs, 1,000+ employees) needing deepest health-score configurability inside a full enterprise CS platform, with budget for $200K+/year.
See full profile →Best for
Mid-market SaaS companies (50-2,000 employees, 5-100 CSMs) wanting Gainsight-class health scoring with built-in product analytics at lower mid-market pricing.
See full profile →Best for
Mid-market SaaS companies (50-500 employees) wanting affordable health scoring with tight Salesforce integration without Gainsight complexity.
See full profile →Related editorial
Last updated 2026-05-23. Editorial verdict based on the published Top 10 Customer Health Scoring Software for 2026 ranking. Disagree? Tell us.